tiziano oldoni, MD
Italfarmaco
1
0
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Charles A. Linker, M.D.
University of California, San Francisco
Shared therapeutic areas:
Marcin Wlodarski, MD, PhD
St. Jude Children's Research Hospital
Shared therapeutic areas:
Richard E. Champlin, MD, BS
M.D. Anderson Cancer Center
Shared therapeutic areas:
Srdan Verstovsek, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Richard E. Champlin, MD,BS
M.D. Anderson Cancer Center
Shared therapeutic areas:
Uday Popat, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Guillermo Garcia-Manero, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Enrico Derenzini, MD
Istituto Europeo di Oncologia
Shared therapeutic areas:
Alessandro Rambaldi, MD
A.O. Ospedale Papa Giovanni XXIII
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases
All 1 trials loaded